
    
      The dose escalation part of the trial will be concerned on adults with advanced solid tumor
      with bone metastasis and young and adult patients with unresectable locally advanced or
      metastatic osteosarcoma.

      The Expansion cohort will be conducted on young and adult patients with unresectable locally
      advanced or metastatic osteosarcoma.
    
  